Copertina

Pathogenic mechanisms and etiologic aspects of Mycobacterium avium subspecies paratuberculosis as an infectious cause of cutaneous melanoma

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Ellen S. Pierce, Charulata Jindal, Yuk Ming Choi, Kaitlin Cassidy, Jimmy T. Efird
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2024
Soggetti:	MedComm – Oncology
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Unraveling the underlying mechanisms of cancer stem cells in therapeutic resistance for optimizing treatment strategies
di: Yunhan Tan, et al.
Pubblicazione: (2025)

Clinical homologous recombination repair gene reversion analysis identifies mechanisms of resistance to PARP inhibitors and platinum‐chemotherapy
di: Yan Jia, et al.
Pubblicazione: (2024)

LncRNA SNHG5/miR‐363‐3p/USP28 Axis Promotes Lung Adenocarcinoma Progression Through Enhancing β‐Catenin Stabilization
di: Jia‐yu Zou, et al.
Pubblicazione: (2025)

Oxidative Stress and DNA Epigenetic Modifications in Cancer: Mechanisms and Targeted Therapeutics
di: Xishan Yang, et al.
Pubblicazione: (2026)

Local Anesthetics in Cancer: Mechanisms and Translational Perspectives
di: Wan‐li Wang, et al.
Pubblicazione: (2026)

Aging‐Derived Alterations in Genomic, Immune, and Metabolic Networks: Implications for Cancer Development and Therapy
di: Qi Wang, et al.
Pubblicazione: (2026)

Issue Information
Pubblicazione: (2024)

CSF@E‐Hn: A bone marrow‐targeted nanosystem for advanced treatment of hematological malignancies
di: Yinyan Jiang, et al.
Pubblicazione: (2024)

Colorectal Cancer Cells Promote de novo Glycine Synthesis for Collagen Production in Cancer‐Associated Fibroblasts by Secreting TGF‐β1
di: Chunqi Liu, et al.
Pubblicazione: (2025)

Alcohol Dehydrogenase 4‐Mediated Retinol Metabolism Inhibits Hepatocellular Carcinoma Progression Through Inhibiting the Wnt/β‐Catenin Pathway
di: Jiaying Li, et al.
Pubblicazione: (2025)

Issue Information
Pubblicazione: (2025)

Lomitapide: Targeting METTL3 to Overcome Osimertinib Resistance in NSCLC Through Autophagy Activation
di: Xiaohui Du, et al.
Pubblicazione: (2025)

The Dual Role of Autophagy in Cancer: Mechanisms and Therapeutic Strategies
di: Xiang‐Zheng Gao, et al.
Pubblicazione: (2026)

Targeting Immune Checkpoints: Basic Signaling Pathways and Clinical Translation in Cancer Therapeutics
di: Han Sun, et al.
Pubblicazione: (2025)

The prognostic value of microRNA‐200 family expression in digestive system tumors: A meta‐analysis and validation
di: Xiaoshuang Wu, et al.
Pubblicazione: (2024)

KMT2C/D deficiency promotes breast cancer metastasis by regulating KDM6A‐mediated epigenetic remodeling
di: Zhao Huang, et al.
Pubblicazione: (2024)

Insight into Janus kinases specificity: From molecular architecture to cancer therapeutics
di: Tian‐Hua Wei, et al.
Pubblicazione: (2024)

The Acidic Conductor: How Tumor Acidosis Orchestrates Metabolic Adaptation
di: Chen Xu, et al.
Pubblicazione: (2026)

Lactate: A Key Promoter of Cancer Stem Cells and Implications for Cancer Therapy
di: Yan Xue, et al.
Pubblicazione: (2025)

miRNA interplay: Mechanisms and therapeutic interventions in cancer
di: Zehua Wang, et al.
Pubblicazione: (2024)

Redox regulation of cancer stem cells: Biology and therapeutic implications
di: Min Du, et al.
Pubblicazione: (2024)

Oncofetal Biology: From Fundamental Mechanisms to Emerging Therapeutic Opportunities
di: Yang Liu, et al.
Pubblicazione: (2026)

Pharmacokinetics comparison of aumolertinib, osimertinib, gefitinib and their major metabolites in mouse model and NSCLC patients
di: Ran Ren, et al.
Pubblicazione: (2024)

X‐Linked Inhibitor of Apoptosis Protein (XIAP) Contributes to ERK1/2‐Mediated Anoikis Resistance in Hepatocellular Carcinoma
di: Qingyu Zeng, et al.
Pubblicazione: (2026)

Multifacet Roles of Cellular Senescence in Cancer: Mechanisms and Therapeutic Implications
di: Huajie Mao, et al.
Pubblicazione: (2026)

Deciphering transcriptional bursts and enhancer dynamics: Advancing cancer therapeutics through single‐cell global run‐on sequencing
di: Xiangyu Pan, et al.
Pubblicazione: (2024)

Targeting iron–sulfur cluster assembly scaffold protein as a vulnerability in KRAS‐activated pancreatic ductal adenocarcinoma
di: Huarui Cai, et al.
Pubblicazione: (2024)

The Interplay of Aging and Cancer: Mechanisms, Implications, and Therapeutic Strategies
di: Liangce Wang, et al.
Pubblicazione: (2025)

The Role of Glycoprotein Non‐Metastatic Melanoma Protein B (GPNMB) in Tumors and Other Diseases
di: Zhenyu Wu, et al.
Pubblicazione: (2025)

PGE2‐EP2/EP4 axis: A new perspective on cancer immunotherapy
di: Lin Chen, et al.
Pubblicazione: (2024)

Targeting LAG‐3 restores CD8+ T cell effector function through CD94/NKG2‐Qa‐1b signaling
di: Zhiqiang Wang, et al.
Pubblicazione: (2024)

The Acetyl‐CoA‐NLRX1 Axis Acts as a Key Player in Mitophagy and Drug Resistance
di: Ping Jin, et al.
Pubblicazione: (2026)

Zinc‐Coordination‐Driven Pyroptosis Nano‐Inductor Sensitizes Colorectal Cancer Chemo‐Immunotherapy by Specific Delivery and Cell Stemness Suppression
di: Qinxia Chang, et al.
Pubblicazione: (2026)

Analysis of reoperational reason of patients with thyroid cancer and strategies for its diagnosis and treatment: A 6‐year single‐center retrospective study
di: Rongli Xie, et al.
Pubblicazione: (2025)

Mechanism and application of acupuncture and electro‐acupuncture associated with cancer therapy
di: Xinggang Yang, et al.
Pubblicazione: (2024)

Cathepsin B‐Responsive Dendronized‐Hyaluronic Acid Nanomedicine for Simultaneous Cancer Theranostics
di: Chunhua Guo, et al.
Pubblicazione: (2025)

The Epstein–Barr Virus Envelope Glycoprotein BALF4 Promotes the Ubiquitination and Degradation of RNA Acetyltransferase NAT10 Suppressing Gastric Cancer Progression
di: Tianle Qiu, et al.
Pubblicazione: (2025)

Next‐generation sequencing identifies that protein tyrosine phosphatase receptor type D mutation is favorable to immunotherapy in human cancer
di: Yongsheng Huang, et al.
Pubblicazione: (2024)

Enhancing cancer immunotherapy and antiangiogenic therapy by regulating gut microbes: Opportunities and challenges
di: Jie Xu, et al.
Pubblicazione: (2024)

Extracellular vesicles in cancer drug resistance: Mechanistic insights and therapeutic implications
di: Jing Zuo, et al.
Pubblicazione: (2024)